| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis. | Antimicrob Agents Chemother | 2012 | 1.83 |
| 2 | Contribution of moxifloxacin or levofloxacin in second-line regimens with or without continuation of pyrazinamide in murine tuberculosis. | Am J Respir Crit Care Med | 2013 | 1.65 |
| 3 | Activity of the fluoroquinolone DC-159a in the initial and continuation phases of treatment of murine tuberculosis. | Antimicrob Agents Chemother | 2011 | 0.78 |